Alpha Tau Medical (DRTS) Income from Continuing Operations (2021 - 2026)

Alpha Tau Medical has reported Income from Continuing Operations for 6 years, with the latest figure at 22950000.0 in Q1 2026.

• Quarterly Income from Continuing Operations rose 170.22% year-over-year to 22950000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 56842000.0 (up 76.24% YoY) and the FY2025 annual result came in at 42385000.0, up 33.55% from the prior year.
• Income from Continuing Operations advanced to 22950000.0 in Q1 2026 per DRTS's latest filing, from 12206000.0 in the prior quarter.
• Over five years, Income from Continuing Operations peaked at 25740000.0 in Q1 2022 and troughed at 1987000.0 in Q2 2022.
• A 5-year average of 9407058.82 and a median of 8145000.0 in 2023 frame the typical range for Income from Continuing Operations.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations sank 71.42% in 2022, then soared 334.88% in 2023.
• Over 5 years, Income from Continuing Operations stood at 3390000.0 in 2022, then soared by 116.78% to 7349000.0 in 2023, then advanced by 28.89% to 9472000.0 in 2024, then advanced by 28.86% to 12206000.0 in 2025, then soared by 88.02% to 22950000.0 in 2026.
• According to Business Quant data, Income from Continuing Operations over the past three periods registered 22950000.0, 12206000.0, and 11702000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.